Trajectories of interferon-gamma release assay results over two years in independent cohorts from China, South Africa, Tanzania, and the United States
<p><strong>Background:</strong> There is an ongoing debate about whether clearance of Mycobacterium tuberculosis infection occurs and at what magnitude. Recent studies quantifying ‘uncertainty zones’ of interferon-gamma release assays (IGRA) provide a more stringent estimate of rev...
Main Authors: | Chen, C, Xue, H, Horsburgh, CR, Amour, M, Hatherill, M, Tameris, M, von Reyn, CF, Rees, C, Shen, Y, McShane, H, García-Basteiro, AL, Liu, D, Wang, Y, Nathavitharana, RR, Graviss, EA, Shao, Y, Liu, Q, Lu, W, Zhu, L, Martinez, L |
---|---|
Format: | Journal article |
Language: | English |
Published: |
Elsevier
2025
|
Similar Items
-
Publishing vaccine trial results – Does there have to be a delay?
by: McShane, H, et al.
Published: (2014) -
Clinical testing of tuberculosis vaccine candidates
by: Hatherill, M, et al.
Published: (2016) -
The candidate TB vaccine, MVA85A, induces highly durable Th1 responses
by: Tameris, M, et al.
Published: (2014) -
Comparison of haematology and biochemistry parameters in healthy South African infants with laboratory reference intervals.
by: Schmidt, B, et al.
Published: (2017) -
Elevated IgG responses in infants are associated with reduced prevalence of Mycobacterium tuberculosis infection
by: Logan, E, et al.
Published: (2018)